Frequency, severity, and treatment of agitation in young versus elderly patients in the ICU

被引:98
作者
Fraser, GL
Prato, S
Riker, RR
Berthiaume, D
Wilkins, ML
机构
[1] Univ Vermont, Coll Med, Burlington, VT USA
[2] Maine Med Ctr, Dept Crit Care Med, Portland, ME 04102 USA
来源
PHARMACOTHERAPY | 2000年 / 20卷 / 01期
关键词
D O I
10.1592/phco.20.1.75.34663
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Study Objective. To study the frequency, duration, severity, and treatment of agitation in patients in the intensive care unit (ICU) to determine if the elderly represent a distinct population. Design. Prospective cohort study. Setting. Tertiary care, 10-bed, multidisciplinary ICU. Patients. All patients older than 18 years of age admitted for longer than 24 hours during a Lt-month period. Interventions. None. Measurements and Main Results. One hundred thirty patients were studied for 916 patient-days; 63 (48%) were elderly (> 65 yrs). Nurses and physicians described agitated behavior in 92 patients (70.8%) during 534 (58.3%) patient-days, and it was severe or dangerous in 60 patients (46.1%) during 273 (30%) patient-days. There were no age-related differences in frequency, severity, and duration of agitation. Opiates, benzodiazepines, and haloperidol were administered during 72%, 62%, and 29% of agitated patient-days, respectively. Haloperidol was administered more often to elderly patients (p=0.015); otherwise no between-group differences were noted. Daily dosing requirements were less in the elderly for intermittent intravenous lorazepam, haloperidol, and morphine but not for midazolam (p=0.15). When these dosages were corrected for body mass, no statistical differences between young and old were found. Conclusion. In the ICU, the elderly are not a distinct population for agitation.
引用
收藏
页码:75 / 82
页数:8
相关论文
共 39 条
[1]  
Adams F, 1986, Psychosomatics, V27, P33
[2]   DRUG-USE IN THE NURSING-HOME [J].
AVORN, J ;
GURWITZ, JH .
ANNALS OF INTERNAL MEDICINE, 1995, 123 (03) :195-204
[3]  
Bizek K S, 1995, Crit Care Nurs Clin North Am, V7, P315
[4]   PROPOFOL VS MIDAZOLAM IN SHORT-TERM, MEDIUM-TERM, AND LONG-TERM SEDATION OF CRITICALLY ILL PATIENTS - A COST-BENEFIT-ANALYSIS [J].
CARRASCO, G ;
MOLINA, R ;
COSTA, J ;
SOLER, JM ;
CABRE, L .
CHEST, 1993, 103 (02) :557-564
[5]   Lorazepam and midazolam in the intensive care unit: A randomized, prospective, multicenter study of hemodynamics, oxygen transport, efficacy, and cost [J].
Cernaianu, AC ;
DelRossi, AJ ;
Flum, DR ;
Vassilidze, TV ;
Ross, SE ;
Cilley, JH ;
Grosso, MA ;
Boysen, PG .
CRITICAL CARE MEDICINE, 1996, 24 (02) :222-228
[6]  
CHELLURI L, 1995, ARCH INTERN MED, V155, P103
[7]  
CRIPPEN DW, 1990, CRIT CARE CLIN, V6, P369
[8]   PHARMACOLOGICAL TREATMENT OF BRAIN FAILURE AND DELIRIUM [J].
CRIPPEN, DW .
CRITICAL CARE CLINICS, 1994, 10 (04) :733-766
[9]   PATTERNS OF PRESCRIBING AND ADMINISTERING DRUGS FOR AGITATION AND PAIN IN PATIENTS IN A SURGICAL INTENSIVE-CARE UNIT [J].
DASTA, JF ;
FUHRMAN, TM ;
MCCANDLES, C .
CRITICAL CARE MEDICINE, 1994, 22 (06) :974-980
[10]   USE OF SEDATIVES AND ANALGESICS IN A SURGICAL INTENSIVE-CARE UNIT - A FOLLOW-UP AND COMMENTARY [J].
DASTA, JF ;
FUHRMAN, TM ;
MCCANDLES, C .
HEART & LUNG, 1995, 24 (01) :76-78